virotherapist documents

Talimogene laherparepvec (T-VEC, OncoVEX GM-CSF) phase 3 data in melanoma presented at virotherapy symposium Oxford, April 2014
Health & Medicine Talimogene laherparepvec (T-VEC, OncoVEX GM-CSF) phase 3 data in melanoma presented at virotherapy symposium Oxford, April 2014
Cavatak Oxford Virotherapy Symposium talk
Health & Medicine Cavatak Oxford Virotherapy Symposium talk